Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.38 EUR | +1.81% | +6.12% | +6.96% |
Apr. 26 | FAES FARMA : Q1 beat; full-year guidance re-affirmed | |
Feb. 27 | FAES FARMA : Q4 profitability exceeded expectations |
Sales 2024 * | 476M 509M | Sales 2025 * | 496M 531M | Capitalization | 1.05B 1.12B |
---|---|---|---|---|---|
Net income 2024 * | 89M 95.16M | Net income 2025 * | 91M 97.3M | EV / Sales 2024 * | 2.23 x |
Net Debt 2024 * | 9.8M 10.48M | Net cash position 2025 * | 64.45M 68.91M | EV / Sales 2025 * | 1.99 x |
P/E ratio 2024 * |
11.7
x | P/E ratio 2025 * |
11.4
x | Employees | 1,748 |
Yield 2024 * |
4.59% | Yield 2025 * |
4.66% | Free-Float | 91.13% |
1 day | +1.81% | ||
1 week | +6.12% | ||
Current month | +7.47% | ||
1 month | +6.79% | ||
3 months | +9.39% | ||
6 months | +16.75% | ||
Current year | +6.96% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Chief Executive Officer | - | - | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 18-06-18 | |
Chairman | - | 91-05-15 | |
Director/Board Member | - | 94-06-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 773 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.38 | +1.81% | 352,943 |
24-04-25 | 3.32 | +1.37% | 297,907 |
24-04-24 | 3.275 | -0.30% | 316,838 |
24-04-23 | 3.285 | +3.30% | 435,056 |
24-04-22 | 3.18 | -0.16% | 197,605 |
Delayed Quote BME, April 26, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.96% | 1.11B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- FAE Stock